Reuters  Sep 25  Comment 
IHS Inc is preparing to submit an offer next week for Solera Holdings Inc, the software maker that agreed this month to sell itself to Vista Equity Partners LLC for $6.5 billion,...
Benzinga  Sep 22  Comment 
Vascular Biogenics Ltd (NASDAQ: VBLT) shares climbed 23.95 percent to $10.04. The volume of Vascular Biogenics shares traded was 6123 percent higher than normal. On Monday, Chardan Capital initiated coverage on Vascular Biogenics with a Buy rating...
Canada.com  Sep 14  Comment 
NEW YORK, N.Y. - Stocks that moved substantially or traded heavily Monday on the New York Stock Exchange and the Nasdaq Stock Market:
Benzinga  Sep 14  Comment 
Collegium Pharmaceutical Inc (NASDAQ: COLL) shares climbed 40.52 percent to $18.90. The volume of Collegium Pharmaceutical shares traded was 4952 percent higher than normal. Collegium Pharmaceutical reported that the FDA Advisory Committees have...
Benzinga  Sep 14  Comment 
Following the market opening Monday, the Dow traded down 0.51 percent to 16,349.14 while the NASDAQ slipped 0.36 percent to 4,805.04. The S&P also fell, dropping 0.47 percent to 1,951.92. Leading and Lagging Sectors In trading on Monday,...
Benzinga  Sep 14  Comment 
Analysts at Raymond James downgraded Manning and Napier Inc (NYSE: MN) from Outperform to Market Perform. Manning & Napier shares closed at $8.32 on Friday. Baird downgraded Solera Holdings Inc (NYSE: SLH) to Neutral. The target price for Solera...
TheStreet.com  Sep 14  Comment 
NEW YORK (TheStreet) -- Solera Holdings  stock is soaring by 9.57% to $54.18 in pre-market trading on Monday, after the company announced yesterday it had agreed to be acquired by an affiliate of private-equity firm Vista Equity Partners. ...
New York Times  Sep 14  Comment 
The private equity firm will purchase all of the outstanding shares in cash of Solera, which provides software to insurance and car companies.



Wikinvest © 2006, 2007, 2008, 2009, 2010, 2011, 2012. Use of this site is subject to express Terms of Service, Privacy Policy, and Disclaimer. By continuing past this page, you agree to abide by these terms. Any information provided by Wikinvest, including but not limited to company data, competitors, business analysis, market share, sales revenues and other operating metrics, earnings call analysis, conference call transcripts, industry information, or price targets should not be construed as research, trading tips or recommendations, or investment advice and is provided with no warrants as to its accuracy. Stock market data, including US and International equity symbols, stock quotes, share prices, earnings ratios, and other fundamental data is provided by data partners. Stock market quotes delayed at least 15 minutes for NASDAQ, 20 mins for NYSE and AMEX. Market data by Xignite. See data providers for more details. Company names, products, services and branding cited herein may be trademarks or registered trademarks of their respective owners. The use of trademarks or service marks of another is not a representation that the other is affiliated with, sponsors, is sponsored by, endorses, or is endorsed by Wikinvest.
Powered by MediaWiki